购物车
- 全部删除
- 您的购物车当前为空
AD1058 是一种ATR抑制剂,具有口服活性、选择性以及能透过血脑屏障(IC50= 1.6 nM)。该化合物在体内展现出防癌效果,能够抑制细胞增殖、干扰细胞周期并诱导细胞凋亡(Apoptosis)。此外,AD1058 适用于研究由晚期实体瘤导致的脑部和中枢神经系统转移。
AD1058 是一种ATR抑制剂,具有口服活性、选择性以及能透过血脑屏障(IC50= 1.6 nM)。该化合物在体内展现出防癌效果,能够抑制细胞增殖、干扰细胞周期并诱导细胞凋亡(Apoptosis)。此外,AD1058 适用于研究由晚期实体瘤导致的脑部和中枢神经系统转移。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | AD1058, a selective and blood-brain barrier permeable ATR inhibitor, is orally active and demonstrates potent in vivo anticancer effects. It effectively inhibits cell proliferation, disrupts the cell cycle, and induces Apoptosis. AD1058 is particularly useful for research involving brain and central nervous system metastases from advanced solid tumors. |
靶点活性 | ATR:1.6 nM, mTOR:45.83 nM, LCK:2594.00 nM, ARK5:7314.00 nM |
分子量 | 412.47 |
分子式 | C19H20N6O3S |
CAS No. | 2907782-78-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.